Eminence Capital’s CVS Health CVS Stock Holding History

Eminence Capital’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-244,313	Closed	-$18.4M	–	75
2021 Q1	$18.4M	Buy	+244,313	New	+$17.8M	0.23%	64

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eminence Capital's CVS Position: Q2 2021 in Review

Eminence Capital sold out of CVS Health (CVS) in Q2 2021, closing a stake of 244,313 shares — an estimated $18.4M sold.

Eminence Capital first reported a position in CVS in Q1 2021 and held it in 1 quarter. The position peaked at $18.4M in Q1 2021. 2,065 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

Eminence Capital reported no remaining CVS Health position as of Q2 2021 after selling out during the quarter.
Eminence Capital sold 244,313 CVS Health shares in Q2 2021, an estimated $18.4M.
Eminence Capital first reported a position in CVS Health in Q1 2021 and held it in 1 quarter.
Eminence Capital's CVS Health position peaked at $18.4M in Q1 2021.
2,065 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on Eminence Capital's 13F filing for Q2 2021, filed 16 Aug 2021.